Feb 21 U.S. drugmaker Merck & Co, already one of the leaders in the hot area of cancer immunotherapy, said on Wednesday it had agreed to buy Viralytics for 502 million Australian dollars ($394 million) to expand its drug pipeline.
* MERCK AND VIRALYTICS ANNOUNCE ACQUISITION AGREEMENT, EXPANDING MERCK'S LEADING IMMUNO-ONCOLOGY PIPELINE
* Says its top shareholder Takeda Pharmaceutical Company Limited will cut voting power in the company to 5.4 percent from 12.6 percent, and will become the third biggest shareholder of the company, effective Feb. 27
* Private equity firms had bid for CJ HealthCare, local paper had said
* REPORTED ON TUESDAY PRELIM JAN. REVENUE OF 412,700 ZLOTYS, UP 12.8 PERCENT YEAR-ON-YEAR
NEW DELHI The Central Bureau of Investigation (CBI) has arrested a senior official of state-run Punjab National Bank (PNB), the agency said on Wednesday, as an inquiry into a $1.8-billion fraud at the bank expands a week after it unveiled the size of the alleged scam.